These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10103210)

  • 1. Integron-mediated rifampin resistance in Pseudomonas aeruginosa.
    Tribuddharat C; Fennewald M
    Antimicrob Agents Chemother; 1999 Apr; 43(4):960-2. PubMed ID: 10103210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
    Alexander DC; Jones JR; Liu J
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes.
    Naas T; Mikami Y; Imai T; Poirel L; Nordmann P
    J Bacteriol; 2001 Jan; 183(1):235-49. PubMed ID: 11114922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase.
    Arlet G; Nadjar D; Herrmann JL; Donay JL; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2971-2. PubMed ID: 11583008
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on rifampin resistance in the Legionellaceae.
    Serr A; Koenig BF; Heep M; Nielsen K; Bangsborg JM
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2181-2. PubMed ID: 11441826
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.
    Baysarowich J; Koteva K; Hughes DW; Ejim L; Griffiths E; Zhang K; Junop M; Wright GD
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4886-91. PubMed ID: 18349144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria.
    Agrawal P; Varada R; Sah S; Bhattacharyya S; Varshney U
    J Bacteriol; 2018 Mar; 200(6):. PubMed ID: 29311276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa.
    Naas T; Poirel L; Nordmann P
    Biochim Biophys Acta; 1999 Dec; 1489(2-3):445-51. PubMed ID: 10673049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.
    Huitric E; Werngren J; Juréen P; Hoffner S
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2860-2. PubMed ID: 16870787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene.
    Quan S; Imai T; Mikami Y; Yazawa K; Dabbs ER; Morisaki N; Iwasaki S; Hashimoto Y; Furihata K
    Antimicrob Agents Chemother; 1999 Jan; 43(1):181-4. PubMed ID: 9869590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay.
    Marttila HJ; Soini H; Vyshnevskiy BI; Otten TF; Vasilyef AV; Huovinen P; Viljanen MK
    Scand J Infect Dis; 1998; 30(2):129-32. PubMed ID: 9730297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic.
    Quan S; Venter H; Dabbs ER
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2456-60. PubMed ID: 9371349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis.
    Wang Q; Yue J; Zhang L; Xu Y; Chen J; Zhang M; Zhu B; Wang H; Wang H
    J Proteome Res; 2007 Dec; 6(12):4564-71. PubMed ID: 17970586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa.
    Yee YC; Kisslinger B; Yu VL; Jin DJ
    J Antimicrob Chemother; 1996 Jul; 38(1):133-7. PubMed ID: 8858465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.
    Weinstein ZB; Zaman MH
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic.
    Andersen SJ; Quan S; Gowan B; Dabbs ER
    Antimicrob Agents Chemother; 1997 Jan; 41(1):218-21. PubMed ID: 8980786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.
    Poirel L; Lambert T; Türkoglü S; Ronco E; Gaillard J; Nordmann P
    Antimicrob Agents Chemother; 2001 Feb; 45(2):546-52. PubMed ID: 11158753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique.
    Caugant DA; Sandven P; Eng J; Jeque JT; Tønjum T
    Microb Drug Resist; 1995; 1(4):321-6. PubMed ID: 9158803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.
    Klein JL; Brown TJ; French GL
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3056-8. PubMed ID: 11600355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme.
    Toleman MA; Biedenbach D; Bennett D; Jones RN; Walsh TR
    J Antimicrob Chemother; 2003 Oct; 52(4):583-90. PubMed ID: 12951335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.